These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Circulating soluble interleukin 2 receptor concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism. Mariotti S; Caturegli P; Barbesino G; Del Prete GF; Chiovato L; Pinchera A J Endocrinol Invest; 1991 Oct; 14(9):777-81. PubMed ID: 1761814 [TBL] [Abstract][Full Text] [Related]
4. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis. Rieu M; Richard A; Rosilio M; Laplanche S; Ropion V; Fombeur JP; Berrod JL Clin Endocrinol (Oxf); 1994 Apr; 40(4):529-35. PubMed ID: 8187321 [TBL] [Abstract][Full Text] [Related]
5. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Bogazzi F; Bartalena L; Brogioni S; Burelli A; Manetti L; Tanda ML; Gasperi M; Martino E Eur J Endocrinol; 1999 May; 140(5):452-6. PubMed ID: 10229913 [TBL] [Abstract][Full Text] [Related]
6. The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases. Jiskra J; Antosová M; Límanová Z; Telicka Z; Lacinová Z Clin Exp Immunol; 2009 May; 156(2):211-6. PubMed ID: 19250272 [TBL] [Abstract][Full Text] [Related]
7. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry. Chan JY; Walfish PG J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483 [TBL] [Abstract][Full Text] [Related]
12. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease. Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308 [TBL] [Abstract][Full Text] [Related]
13. Hashimoto's thyroiditis following Graves' disease. Umar H; Muallima N; Adam JM; Sanusi H Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of serum interleukin-18 in Graves' disease. Miyauchi S; Matsuura B; Onji M Thyroid; 2000 Sep; 10(9):815-9. PubMed ID: 11041460 [TBL] [Abstract][Full Text] [Related]
15. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases. Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577 [TBL] [Abstract][Full Text] [Related]
16. Serum soluble interleukin-2 receptors as an index of the biological activity of thyroid hormones in hyperthyroidism. Koukkou E; Panayiotidis P; Thalassinos N J Endocrinol Invest; 1995 Apr; 18(4):253-7. PubMed ID: 7560805 [TBL] [Abstract][Full Text] [Related]
17. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis. Chan JY; Walfish PG Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193 [TBL] [Abstract][Full Text] [Related]
18. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism. Koukkou E; Panayiotidis P; Alevizou-Terzaki V; Thalassinos N J Clin Endocrinol Metab; 1991 Oct; 73(4):771-6. PubMed ID: 1909702 [TBL] [Abstract][Full Text] [Related]